Literature DB >> 8751928

Uptake of Streptococcus pneumoniae by respiratory epithelial cells.

U M Talbot1, A W Paton, J C Paton.   

Abstract

Although Streptococcus pneumoniae is the leading cause of community-acquired pneumonia in humans, the mechanism whereby the organism penetrates lung tissue is poorly understood. In the present study we have examined the capacity of pneumococci to penetrate A549 cells, a human lung alveolar carcinoma (type II pneumocyte) cell line. Not all clinical S. pneumoniae isolates initially tested were capable of penetration of the cells, as judged by resistance to extracellular antibiotics. The presence of a polysaccharide capsule also significantly reduced the capacity to both adhere to and penetrate A549 cells. Electron micrographs showed the presence of pneumococci enclosed within vacuoles of intact A549 cells, but bacteria were also seen free in the cytoplasm of damaged cells. Ongoing bacterial DNA, RNA, or protein synthesis was not essential for uptake of pneumococci by A549 cells, and uptake was not diminished by pretreatment of the pneumococci with trypsin. However, inhibition of A549 microfilament assembly with cytochalasin D abolished the phenomenon.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8751928      PMCID: PMC174292          DOI: 10.1128/iai.64.9.3772-3777.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Respiratory epithelial cell invasion by group B streptococci.

Authors:  C E Rubens; S Smith; M Hulse; E Y Chi; G van Belle
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

2.  Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence.

Authors:  C E Rubens; M R Wessels; L M Heggen; D L Kasper
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

Review 3.  Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment.

Authors:  D M Musher
Journal:  Clin Infect Dis       Date:  1992-04       Impact factor: 9.079

4.  Effect of type III group B streptococcal capsular polysaccharide on invasion of respiratory epithelial cells.

Authors:  M L Hulse; S Smith; E Y Chi; A Pham; C E Rubens
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

5.  Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization.

Authors:  J N Weiser; R Austrian; P K Sreenivasan; H R Masure
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

6.  Correlation of epithelial cell invasiveness of group B streptococci with clinical source of isolation.

Authors:  P Valentin-Weigand; G S Chhatwal
Journal:  Microb Pathog       Date:  1995-08       Impact factor: 3.738

7.  Destruction of low efficiency markers is a slow process occurring at a heteroduplex stage of transformation.

Authors:  N B Shoemaker; W R Guild
Journal:  Mol Gen Genet       Date:  1974

8.  Interruption of capsule production in Streptococcus pneumonia serotype 3 by insertion of transposon Tn916.

Authors:  D A Watson; D M Musher
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

9.  The cell wall mediates pneumococcal attachment to and cytopathology in human endothelial cells.

Authors:  S Geelen; C Bhattacharyya; E Tuomanen
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

10.  Isolation, characterization, and nucleotide sequence of IS1202, an insertion sequence of Streptococcus pneumoniae.

Authors:  J K Morona; A Guidolin; R Morona; D Hansman; J C Paton
Journal:  J Bacteriol       Date:  1994-07       Impact factor: 3.490

View more
  64 in total

1.  Peritoneal culture alters Streptococcus pneumoniae protein profiles and virulence properties.

Authors:  C J Orihuela; R Janssen; C W Robb; D A Watson; D W Niesel
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  Activities of antimicrobial agents against intracellular pneumococci.

Authors:  G L Mandell; E J Coleman
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

3.  Pneumococcal 6-phosphogluconate-dehydrogenase, a putative adhesin, induces protective immune response in mice.

Authors:  D Daniely; M Portnoi; M Shagan; A Porgador; N Givon-Lavi; E Ling; R Dagan; Y Mizrachi Nebenzahl
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

4.  Interleukin-1β regulates CXCL8 release and influences disease outcome in response to Streptococcus pneumoniae, defining intercellular cooperation between pulmonary epithelial cells and macrophages.

Authors:  Helen M Marriott; Kate A Gascoyne; Ravi Gowda; Ian Geary; Martin J H Nicklin; Francesco Iannelli; Gianni Pozzi; Timothy J Mitchell; Moira K B Whyte; Ian Sabroe; David H Dockrell
Journal:  Infect Immun       Date:  2011-12-12       Impact factor: 3.441

5.  Deletion of arcD in Streptococcus pneumoniae D39 impairs its capsule and attenuates virulence.

Authors:  Radha Gupta; Jun Yang; Yimin Dong; Edwin Swiatlo; Jing-Ren Zhang; Dennis W Metzger; Guangchun Bai
Journal:  Infect Immun       Date:  2013-08-05       Impact factor: 3.441

6.  Moxifloxacin and azithromycin but not amoxicillin protect human respiratory epithelial cells against streptococcus pneumoniae in vitro when administered up to 6 hours after challenge.

Authors:  Martina Ulrich; Cordula Albers; Jan-Georg Möller; Axel Dalhoff; Gisela Korfmann; Frank Künkele; Gerd Döring
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

7.  Adherence of Streptococcus pneumoniae to human bronchial epithelial cells (BEAS-2B).

Authors:  J E Adamou; T M Wizemann; P Barren; S Langermann
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

8.  High-frequency invasion of epithelial cells by Streptococcus pyogenes can be activated by fibrinogen and peptides containing the sequence RGD.

Authors:  D R Cue; P P Cleary
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

9.  Position of O-Acetylation within the Capsular Repeat Unit Impacts the Biological Properties of Pneumococcal Serotypes 33A and 33F.

Authors:  Brady L Spencer; Jamil S Saad; Anukul T Shenoy; Carlos J Orihuela; Moon H Nahm
Journal:  Infect Immun       Date:  2017-06-20       Impact factor: 3.441

10.  The ClpP protease of Streptococcus pneumoniae modulates virulence gene expression and protects against fatal pneumococcal challenge.

Authors:  Hyog-Young Kwon; A David Ogunniyi; Moo-Hyun Choi; Suhk-Neung Pyo; Dong-Kwon Rhee; James C Paton
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.